BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3005341)

  • 1. Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor.
    Weissman AM; Klausner RD; Rao K; Harford JB
    J Cell Biol; 1986 Mar; 102(3):951-8. PubMed ID: 3005341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of intracellular iron distribution in K562 human erythroleukemia cells.
    Mattia E; Josic D; Ashwell G; Klausner R; van Renswoude J
    J Biol Chem; 1986 Apr; 261(10):4587-93. PubMed ID: 3457008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dynamic morphology of the transferrin-transferrin receptor system in human leukaemia/lymphoma cell lines and its relation to iron metabolism and cell proliferation.
    Forsbeck K; Nilsson K
    Scand J Haematol; 1985 Aug; 35(2):145-54. PubMed ID: 2996121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9.
    Schneider C; Sutherland R; Newman R; Greaves M
    J Biol Chem; 1982 Jul; 257(14):8516-22. PubMed ID: 6282884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lead on iron uptake from transferrin in human erythroleukemia (K562) cells.
    Kohno H; Taketani S; Tokunaga R
    Biometals; 1993; 6(2):77-83. PubMed ID: 8358209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of K562 cell transferrin receptors by exogenous iron.
    Rudolph NS; Ohlsson-Wilhelm BM; Leary JF; Rowley PT
    J Cell Physiol; 1985 Mar; 122(3):441-50. PubMed ID: 2981898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the transferrin receptor in K562 erythroleukemia cells.
    Cudkowicz A; Klausner RD; Bridges KR
    Prog Clin Biol Res; 1984; 165():509-19. PubMed ID: 6095315
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid internalization of the transferrin receptor in K562 cells is triggered by ligand binding or treatment with a phorbol ester.
    Klausner RD; Harford J; van Renswoude J
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3005-9. PubMed ID: 6328486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular movement of cell surface receptors after endocytosis: resialylation of asialo-transferrin receptor in human erythroleukemia cells.
    Snider MD; Rogers OC
    J Cell Biol; 1985 Mar; 100(3):826-34. PubMed ID: 2982885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of transferrin and uptake of iron by K-562 cells.
    Slørdahl S; Romslo I; Lamvik J
    Scand J Clin Lab Invest; 1984 Oct; 44(6):549-53. PubMed ID: 6091257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalization and recycling of transferrin and its receptor. Effect of trifluoperazine on recycling in human erythroleukemic cells.
    Hunt RC; Marshall-Carlson L
    J Biol Chem; 1986 Mar; 261(8):3681-6. PubMed ID: 3005297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of hepatic transferrin receptor expression in hemochromatosis.
    Sciot R; Paterson AC; Van den Oord JJ; Desmet VJ
    Hepatology; 1987; 7(5):831-7. PubMed ID: 3308665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated endocytosis of transferrin in K562 cells.
    Klausner RD; Van Renswoude J; Ashwell G; Kempf C; Schechter AN; Dean A; Bridges KR
    J Biol Chem; 1983 Apr; 258(8):4715-24. PubMed ID: 6300098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of two distinct transferrin receptor recycling pathways and transferrin-independent receptor internalization in K562 cells.
    Stein BS; Sussman HH
    J Biol Chem; 1986 Aug; 261(22):10319-31. PubMed ID: 3015925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
    Suzuki S; Inoue K; Hongoh A; Hashimoto Y; Yamazoe Y
    Br J Cancer; 1997; 76(1):83-9. PubMed ID: 9218737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron metabolism in K562 erythroleukemic cells.
    Bottomley SS; Wolfe LC; Bridges KR
    J Biol Chem; 1985 Jun; 260(11):6811-5. PubMed ID: 2987233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines.
    Testa U; Louache F; Titeux M; Thomopoulos P; Rochant H
    Br J Haematol; 1985 Jul; 60(3):491-502. PubMed ID: 2990522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron uptake from transferrin and transferrin endocytic cycle in Friend erythroleukemia cells.
    Hradilek A; Neuwirt J
    J Cell Physiol; 1987 Oct; 133(1):192-6. PubMed ID: 3478338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody D51 recognizes the transferrin-receptor structure.
    Gross HJ
    Blut; 1985 Aug; 51(2):117-22. PubMed ID: 2992646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.
    Taetle R; Rhyner K; Castagnola J; To D; Mendelsohn J
    J Clin Invest; 1985 Mar; 75(3):1061-7. PubMed ID: 2984253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.